Hepatitis A, Total

Laboratory Fee Schedule

Procedure: MBE0203A
CPT: 86708

Synonym(s): Enzyme Immunoassay (EIA) for the Detection of total Anti-Hepatitis A Antibodies (IgG and IgM) in Human Serum
Requisition Form G-2A
Test Description An in vitro enzyme immunoassay for the qualitative detection of total antibodies (IgG and IgM) to hepatitis A virus in human serum.
Pre-Approval Needed N/A
Supplemental Information Required N/A
Supplemental Form(s) N/A
Performed on Specimens from (sources) Human
Sample/Specimen Type for Testing Serum
Minimum Volume/Size Required 500 µL.
Storage/Preservation Prior to Shipping Serum separated from the clot may be stored at 2°C to 8°C for up to 48 hours but then must be frozen at -20°C or colder until used.
Transport Medium N/A
Specimen Labeling At least 2 patient specific identifiers: First and last name as one identifier and a DOB or a unique patient specific identifier (e.g. Medical Record number); must match information on submission form (G-2A).
Shipping and Specimen Handling Requirements
  • Ship according to Dangerous Goods Regulations, IATA, and/or CFR 49.
  • Handle as infectious agent using universal precautions.
  • Triple contain in accordance with federal shipping regulations for infectious agents.
    Additional forms & resources
Method EIA for antibody detection
Turn-around Time 4 working days
Interferences/Limitations Bacterial contamination, heterophile antibodies
Common Causes for Rejection
  • Insufficient quantity
  • unacceptable specimen type or source
  • improper shipping conditions
  • expired media or collection container
  • discrepancies between specimen label and submission form
  • incomplete or missing submission form.
Additional Information A reactive HAV result does not exclude co-infection by another hepatitis virus.